Effects of Aβ1-42 fibrils and of the tetrapeptide Pr-IIGL on the phosphorylation state of the τ-protein and on the α7 nicotinic acetylcholine receptor in vitro

European Journal of Neuroscience

Volumn 21, Issue 4, 2005, Pages 879-888

  Lain, Enzo ^a   Penke, Botond ^b   Delacourte, André ^c   Gündisch, Daniela ^d   Schröder, Hannsjörg ^a   Witter, Brigitte ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSERM   (France)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

Bungarotoxin; Hippocampus dissociation culture; Immunocytochemistry; Rat; Western blot

Indexed keywords

ALPHA BUNGAROTOXIN I 125; AMYLOID BETA PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; NEUROPROTECTIVE AGENT; NICOTINIC RECEPTOR; PROPIONYLISOLEUCYLISOLEUCYLGLYCYLLEUCINE; TAU PROTEIN; TETRAPEPTIDE; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); BUNGAROTOXIN; EPITOPE; IODINE; MICROTUBULE ASSOCIATED PROTEIN; MTAP2 PROTEIN, RAT; OLIGOPEPTIDE; PEPTIDE FRAGMENT; PROPIONYL ISOLEUCYL ISOLEUCYL GLYCYL LEUCINAMIDE; PROPIONYL-ISOLEUCYL-ISOLEUCYL-GLYCYL-LEUCINAMIDE; SERINE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DENDRITE; HIPPOCAMPUS; IN VITRO STUDY; NERVE CELL CULTURE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPROTECTION; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR AFFINITY; ANIMAL; CELL COUNT; COMPARATIVE STUDY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; EMBRYO; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; NERVE CELL; PHOSPHORYLATION; RADIOASSAY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; WESTERN BLOTTING;

AMYLOID BETA-PROTEIN; ANIMALS; BLOTTING, WESTERN; BUNGAROTOXINS; CELL COUNT; EMBRYO; EPITOPES; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IODINE ISOTOPES; MICROSCOPY, ELECTRON, TRANSMISSION; MICROTUBULE-ASSOCIATED PROTEINS; NEURONS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RADIOLIGAND ASSAY; RATS; RECEPTORS, NICOTINIC; SERINE; TAU PROTEINS;

EID: 16244369428     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2005.03909.x     Document Type: Article

References (63)

1. Arriagada, P.V., Growdon, J.H., Hedley-Whyte, E.T. & Hyman, B.T. (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology, 42, 631-639.
2. Banket, G.A. & Cowan, W.M. (1977) Rat hippocampal neurons in dispersed cell culture. Brain Res., 126, 397-425.
3. Bourin, M., Ripoli, N. & Dailly, E. (2003) Nicotinic receptors and Alzheimer's disease. Curr. Med. Res. Opin., 19, 169-177.
4. Braak, H. & Braak, E. (1995) Staging of Alzheimer's disease-related neurofibrillary tangles. Neurobiol. Aging, 16, 271-284.
5. Braak, H. & Braak, E. (1998) Evolution of neuronal changes in the course of Alzheimer's disease. J. Neural. Transm. Suppl., 53, 127-140.
6. Brewer, C.J., Torricelli, J.R., Evege, E.K. & Price, P.J. (1993) Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res., 35, 567-576.
7. Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A. & Hof, P.R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res., 33, 95-130.
8. Buée-Scherrer, V., Condamines, O., Mourton-Gilles, C., Jakes, R., Goedert, M., Pau, B. & Delacourte, A. (1996) AD2, a phosphorylation- dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Mol. Brain Res., 39, 79-88.
9. Busciglio, J., Lorenzo, A. & Yankner, B.A. (1992) Methodological variables in the assessment of beta amyloid neurotoxiciry. Neurobiol. Aging, 13, 609-612.
10. Busciglio, J., Lorenzo, A., Yeh, J. & Yankner, B.A. (1995) β-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron, 14, 879-888.
11. Caceres, A., Banker, G., Steward, O., Binder, L. & Payne, M. (1984) MAP2 is localized to the dendrites of hippocampal neurons which develop in culture. Brain Res., 13, 314-418.
12. Castro, N.G. & Albuquerque, E.X. (1995) alpha-Bungarotoxin-sensitive hippocampal nicotinic receptor channel has a high calcium permeability. Biophys. J., 68, 516-524.
13. Dineley, K.T., Bell, K.A., Bui, D. & Sweatt, J.D. (2002) β-amyloid peptide activates α7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. J. Biol Chem., 277, 25056-25061.
14. Dotti, C.G., Sullivan, C.A. & Banker, G.A. (1988) The establishment of polarity by hippocampal neurons in culture. J. Neurosci., 8, 1454-1468.
15. Drisdel, R.C. & Green, W.N. (2000) Neuronal α-bungarotoxin receptors are α7 homomers. J. Neurosci., 20, 133-139.
16. Drouet, B., Pincon-Raymond, M., Chambaz, J. & Pillot, T. (2000) Molecular basis of Alzheimer's disease. Cell. Mol. Life Sci., 57, 705-715.
17. Goedert, M., Crowter, R.A. & Garner, C.C. (1991) Molecular characterization of microtubule-associated proteins tau and MAP2. Trends Neurosci., 14, 193-199.
18. Goedert, M., Jakes, R., Crowther, R.A., Six, J., Lübke, U., Vandermeeren, M., Cras, P., Trojanowski, J.Q. & Lee, V.M.-Y. (1993) The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer's disease recapitulates phosphorylation during development. Proc. Natl Acad. Sci. USA, 90, 5066-5070.
19. Goslin, K., Asmussen, H. & Banker, G. (1998) Rat hippocampal neurons in low density culture. In Banker, G. & Goslin, K. (Eds), Culturing Nerve Cells, 2nd edn. MIT Press, Cambridge, MA, pp. 339-370.
20. Götz, J., Chen, F., van Dorpe, J. & Nitsch, R.M. (2001) Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils. Science, 293, 1491-1495.
21. Grace, E.A. & Busciglio, J. (2003) Aberrant activation of focal adhesion proteins mediates fibrillary amyloid β-induced neuronal dystrophy. J. Neurosci., 23, 493-502.
22. Gravina, S.A., Ho, L., Eckman, C.B., Long, K.E., Otvos, L. Jr, Younkin, L.H., Suzuki, N. & Younkin, S.G. (1995) Amyloid β protein (Aβ) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42 (43). J. Biol. Chem., 270, 7013-7016.
23. Grundke-Iqbal, I., Iqbal, K., Tung, Y.-C., Quinlan, M., Wisniewsky, H.M. & Binder, L.I. (1986) Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc. Natl Acad. Sci. USA, 83, 4913-4917.
24. Guan, Z.Z., Zhang, X., Mousavi, M., Tian, J.Y., Ungar, C. & Nordberg, A. (2001) Suppressed expression of nicotinic acetylcholine receptors by nanomolar β-amyloid peptides in PC12 cells. J. Neural Transm., 108, 1417-1433.
25. Gundersen, H.J. (1986) Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. Thompson. J. Microsc., 143, 3-45.
26. Gundersen, H.J., Bagger, P., Bendtsen, T.F., Evans, S.M., Korbo, L., Marcussen, N., Moller, A., Nielsen, K., Nyengaard, J.R., Pakkenberg, B., Sørensen, F.B., Vesterby, A. & West, M.J. (1988) The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS, 96, 857-881.
27. Hardy, J.A. & Higgins, G.A. (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science, 256, 184-185.
28. Harkany, T., Abraham, I., Laskay, G., Timmerman, W., Jost, K., Zarandi, M., Penke, B., Nyakas, C. & Luiten, P.G. (1999) Propionyl-IIGL tetrapeptide antagonizes β-amyloid excitotoxicity in rat nucleus basalis. Neuroreport, 10, 1693-1698.
29. Hellström-Lindahl, E., Mousavi, M., Zhang, X., Ravid, R. & Nordberg, A. (1999) Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain. Brain Res. Mol. Brain Res., 66, 94-103.
30. Kang, J., Lemaire, H.G., Unterbeck, A., Salbaum, J.M., Masters, C.L., Grzeschik, K.H., Multhaup, G., Beyreuther, K. & Mueller-Hill, B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature, 325, 733-736.
31. Kasa, P. (1986) The cholinergic systems in brain and spinal cord. Prog. Neurobiol., 26, 211-272.
32. Kawarabayashi, T., Younkin, L.H., Saido, T.C., Shoji, M., Hsiao Ashe, K. & Younkin, S.G. (2001) Age dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci., 21, 372-381.
33. Koh, J., Yang, L.L. & Cotman, C.W. (1990) β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitatory damage. Brain Res., 533, 315-320.
34. 2+]i in rat astrocytes. Biochem. Biophys. Res. Commun., 235, 479-481.
35. Lewis, J., Dickson, D.W., Lin, W.L., Chisholm, L., Corral, A., Jones, J., Yen, S.H., Sahara, N., Skipper, L., Yager, D., Eckman, C., Hardy, J., Hutton, M. & McGowan, E. (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science, 293, 1487-1491.
36. Lorenzo, A. & Yankner, B.A. (1994) β-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl Acad. Sci. USA. 91, 12243-12247.
37. Lorenzo, A., Yuan, M., Zhang, Z., Paganetti, P.A., Sturchler-Pierrat, C., Staufenbil, M., Mautino, J., Sol Vigo, F., Sommer, B. & Yankner, B.A. (2000) Amyloid β interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease. Nat. Neurosci., 3, 460-464.
38. Mandelkow, E.-M., Biernat, J., Drewes, G., Gustke, G., Trinczec, B. & Mandelkow, E. (1995) Tau domains, phosphorylation, and interactions with microtubules. Neurobiol. Aging, 16, 335-362.
39. Mandelkow, E.-M. & Mandelkow, E. (1998) Tau in Alzheimer's disease. Trends Cell Biol., 8, 425-427.
40. Mattson, M.P., Tomaselli, K.J. & Rydel, R.E. (1993) Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res., 621, 35-49.
41. 1-42 in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience, 110, 199-211.
42. Perry, E., Martin-Ruiz, C., Lee, M., Griffiths, M., Johnson, M., Piggott, M., Haroutunian, V., Buxbaum, J.D., Nasland, J., Davis, K., Gotti, C., Clementi, F., Tzartos, S., Cohen, O., Soreq, H., Jaros, E., Perry, R., Ballard, C., McKeith, I. & Court, J. (2000) Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewi body diseases. Eur. J. Pharmacol., 30, 215-222.
43. Pike, C.J., Cummings, B.J. & Cotman, C.W. (1992) β-amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology. Neuroreport, 3, 769-772.
44. Pike, C.J., Walencewicz, A.J., Glabe, G.C. & Cotman, C.W. (1991a) Aggregation-related toxicity of synthetic Aβ-amyloid protein in hippocampal cultures. Eur. J. Pharmacol., 207, 367-368.
45. Pike, C.J., Walencewicz, A.J., Glabe, G.C. & Cotman, C.W. (1991b) In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res., 563, 311-314.
46. Rakhilin, S., Drisdel, R.C., Sagher, D., McGehee, D.S., Vallejo, Y. & Green, W.N. (1999) α-bungarotoxin receptors contain α7 subunits in two different disulfide-bonded conformations. J. Biol. Chem., 146, 203-218.
47. Schröder, H., Nyengaard, J.R., Selberis, W., Lain, E., Keller, A., Köhler, C. & Witter, B. (2004) Unbiased morphometrical techniques for the quantitative assessment of cells in primary dissociation cultures. In Evans, S.M., Janson, A.M. & Nyengaard, J.R. (Eds), Quantitative Methods in Neuroscience - a Neuroanatomical Approach. Oxford University Press. Oxford, pp. 301-313.
48. Shafit-Zagardo, B. & Kalcheva, N. (1998) Making sense of the multiple MAP-2 transcripts and their role in neuron. Mol. Neurobiol., 16, 149-162.
49. Snyder, S.W., Ladror, U.S., Wade, W.S., Wang, G.T., Barret, L.W., Matayoshi, E.D., Huffaker, H.J., Krafft, G.A. & Holzman, T.F. (1994) Amyloid-β aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lenghts. Biophys. J., 67, 1216-1228.
50. Sommer, B. (2002) Alzheimer's disease and the amyloid cascade hypothesis: ten years on. Curr. Opin. Pharmacol., 2, 87-92.
51. Takashima, A., Noguchi, K., Sato, K., Hoshino, T. & Imahori, K. (1993) Tau protein kinase I is essential for amyloid β-protein induced neurotoxicity. Proc. Natl Acad. Sci. USA, 90, 7789-7793.
52. Trojanowski, J.Q. & Lee, V.M.-Y. (1995) Phosphorylation of paired helical filament tau in Alzheimer's neurofibrillary lesions: focusing on phosphatases. FASEB J., 9, 1570-1576.
53. Ventimiglia, R., Jones, B.E. & Moller, A. (1995) A quantitative method for morphometric analysis in neuronal cell culture: unbiased estimation of neuron area and number of branch points. J. Neurosci. Methods, 57, 63-66.
54. Walsh, D.M., Klyubin, I., Fadeeva, J.V., Rowan, M.J. & Selkoe, D.J. (2002) Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem. Soc. Trans., 30, 552-557.
55. 1-42 binds to α7 nicotinic acetylcholine receptors with high affinity. J. Biol. Chem., 275, 5626-5632.
56. 1-42 binds selectively with picomolar affinity to α7 nicotinic acetylcholine receptors. J. Neurochem., 75, 1155-1161.
57. Wang, H.-Y., Li, W., Benedetti, N.J. & Lee, D.H.S. (2003) α7 nicotinic acetylcholine receptors mediate β-amyloid peptide-induced tau protein phosphorylation. J. Biol. Chem., 278, 31547-31553.
58. Watanabe, A., Hasegawa, M., Suzuki, M., Takio, K., Morishima-Kawashima, M., Titani, K., Arai, T., Kosik, K.S. & Ihara, Y. (1993) In vivo phosphorylation sites in fetal and adult tau. J. Biol. Chem., 268, 25712-25717.
59. Wevers, A., Monteggia, L., Nowacki, S., Bloch, W., Schütz, U., Lindstrom, J., Pereira, E.F.R., Eisenberg, H., Giacobini, E., de Vos, R.A.I., Jansen Steur, E.N.H., Maelicke, A., Albuquerque, E.X. & Schröder, H. (1999) Expression of nicotinic acetylcholine receptor subunits in Alzheimer's disease: histotopographical correlation with, amyloid plaques and hyperphosphorylated tau-protein. Eur. J. Neurosci., 11, 2551-2565.
60. Wevers, A., Tima, W., Nonn, M., de Vos, R., Jansen Steur, E., Lindstrom, J. & Schröder, H. (2001) Colocalization of nicotine receptor proteins with plaques and tangles in Alzheimer's disease. Soc. Neurosci. Abstracts, 27, no. 487.4.
61. Wiebringhaus, T., Wirak, D., Altman, R., Cahill, K., Duff, K., Ruhland, M., Boess, F., König, G. & Baumann, K. (2000) The effect of presenilin on β-amyloid in knock-in mice carrying the human amyloid precursor protein with Swedish and/or London mutation. Neurobiol. Aging, 21 (S224), 1018.
62. Wolozin, B.L., Pruchnicki, A., Dikinson, D.W. & Davies, P. (1986) A neuronal antigen in the brains of Alzheimer patients. Science, 232, 648-650.
63. Yankner, B.A., Duffy, L.K. & Kirschner, D.A. (1990) Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science, 250, 279-282.